Cas:56536-96-0 1-Cyanotetraline manufacturer & supplier

We serve Chemical Name:1-Cyanotetraline CAS:56536-96-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-Cyanotetraline

Chemical Name:1-Cyanotetraline
CAS.NO:56536-96-0
Synonyms:1,2,3,4-Tetrahydro-1-naphthalenecarbonitrile;UNII:27327TPP91;1-Naphthalenecarbonitrile, 1,2,3,4-tetrahydro-;1,2,3,4-tetrahydronaphthalene-1-carbonitrile
Molecular Formula:C11H11N
Molecular Weight:157.212
HS Code:2926909090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:309.3±21.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.561
PSA:23.79000
Exact Mass:157.089142
LogP:2.40

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1,2,3,4-Tetrahydro-1-naphthalenecarbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2,3,4-tetrahydronaphthalene-1-carbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2,3,4-Tetrahydro-1-naphthalenecarbonitrile Use and application,UNII:27327TPP91 technical grade,usp/ep/jp grade.


Related News: China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases. 1-Cyanotetraline manufacturer China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases. 1-Cyanotetraline supplier The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. 1-Cyanotetraline vendor China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases. 1-Cyanotetraline factory Speaking to Sky News, Raab said he could not confirm the ��precise number�� of those arriving into the UK on Sunday.